BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1966596)

  • 1. Multiplicity of newly established monoclonal antibodies against hepatocellular carcinomas.
    Ohzu K; Hasegawa K; Yamauchi K; Obata H
    J Gastroenterol Hepatol; 1990; 5(6):601-7. PubMed ID: 1966596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody dependent cell-mediated cytotoxicity using hepatocellular carcinoma reactive monoclonal antibody.
    Kuwata T; Haruta I; Hasegawa K; Yamauchi K; Hayashi N
    J Gastroenterol Hepatol; 1998 Feb; 13(2):137-44. PubMed ID: 10221814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production and characterization of anti-human hepatocellular carcinoma monoclonal antibodies].
    Peng H; Cao Z; Zhou S; Wang Z; Lei B; Zhao L
    Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(3):259-62. PubMed ID: 1965504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.
    Yang LJ; Wang WL
    World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic characterization of human hepatocellular carcinoma. Development of in vitro and in vivo immunoassays that use monoclonal antibodies.
    Carlson RI; Ben-Porath E; Shouval D; Strauss W; Isselbacher KJ; Wands JR
    J Clin Invest; 1985 Jul; 76(1):40-51. PubMed ID: 2991342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological analysis and biochemical characterization of monoclonal antibodies defining antigens of human hepatocellular carcinoma.
    Chang KJ; Finstad CL; Chen PD; Knowles DM; Wang CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Feb; 22(1):1-20. PubMed ID: 2551603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-directed therapy for human hepatocellular carcinoma.
    Mohr L; Yeung A; Aloman C; Wittrup D; Wands JR
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S225-31. PubMed ID: 15508088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two mouse hybridomas secreting monoclonal antibodies against human liver carcinoma and their antibody specificity].
    Xie H; Yang ZH; Chen RM; Yao Z; Wang BM; Guo SY; Yan ZF
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):263-70. PubMed ID: 2424200
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel tumor-associated antigen of hepatocellular carcinoma defined by monoclonal antibody E4-65.
    Zou K; Ju J; Xie H
    Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):359-65. PubMed ID: 17492133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo tumour localisation with a monoclonal antibody directed against a membrane antigen on the human hepatocellular carcinoma cell line PLC/PRF/5.
    Dunk AA; Brown D; Weidmann K; Thomas HC
    J Hepatol; 1987 Feb; 4(1):52-61. PubMed ID: 3033060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human monoclonal antibody constructed by lymphocytes from pancreatic cancer patients].
    Tanaka H
    Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):93-101. PubMed ID: 2539553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer.
    Saito H; Tada S; Ebinuma H; Tsunematsu S; Kagawa T; Kumagai N; Inagaki Y; Watanabe T; Tsuchimoto K; Morizane T
    J Gastroenterol; 1994 Dec; 29(6):733-9. PubMed ID: 7874268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A strategy for the production of human monoclonal antibodies].
    Chiba J
    Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel monoclonal antibody raised against human hepatocellular carcinoma.
    Xie Y; Xie H
    Hybridoma; 1998 Oct; 17(5):437-44. PubMed ID: 9873989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro.
    Moradpour D; Compagnon B; Wilson BE; Nicolau C; Wands JR
    Hepatology; 1995 Nov; 22(5):1527-37. PubMed ID: 7590672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro.
    Dong HL; Sui YF; Li ZS; Qu P; Wu W; Ye J; Zhang XM; Lu SY
    Cancer Lett; 2004 Aug; 211(2):219-25. PubMed ID: 15219945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of highly acidic sulfated glycosphingolipids in human hepatocellular carcinoma defined by a series of monoclonal antibodies.
    Hiraiwa N; Fukuda Y; Imura H; Tadano-Aritomi K; Nagai K; Ishizuka I; Kannagi R
    Cancer Res; 1990 May; 50(10):2917-28. PubMed ID: 2159366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new murine monoclonal antibody against human hepatoma.
    Stein R; Wang ZF; Sharkey RM; Klein KM; Goldenberg DM
    Hybridoma; 1991 Apr; 10(2):255-67. PubMed ID: 1651901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma.
    Takahashi H; Ozturk M; Wilson B; Maki A; Ozawa K; Koizumi M; Endo K; Strauss W; Shouval D; Wands J
    Hepatology; 1989 Apr; 9(4):625-34. PubMed ID: 2538386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cells.
    Hu CP; Han SH; Lui WY; Hsu HC; Lin YM; Lin PH; Chen LR; Hsieh HG; Kuo PT; P'eng FK
    Hepatology; 1986; 6(6):1396-402. PubMed ID: 3025071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.